Metropolitan Life Insurance Company (MetLife)’s Ingersoll Rand IR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio IR Stock Details IR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,326	Closed	-$1.55M	–	1055
2024 Q1	$1.55M	Sell	16,326 -150	-0.9%	-$12.8K	0.07%	251
2023 Q4	$1.27M	Sell	16,476 -255	-2%	-$17.4K	0.06%	277
2023 Q3	$1.07M	Sell	16,731 -896	-5%	-$59.6K	0.06%	288
2023 Q2	$1.15M	Sell	17,627 -483	-3%	-$28.6K	0.06%	298
2023 Q1	$1.05M	Sell	18,110 -5,310	-23%	-$299K	0.05%	312
2022 Q4	$1.22M	Sell	23,420 -583	-2%	-$29.8K	0.05%	318
2022 Q3	$1.04M	Sell	24,003 -445	-2%	-$21K	0.05%	348
2022 Q2	$1.03M	Sell	24,448 -705	-3%	-$32.1K	0.05%	362
2022 Q1	$1.27M	Sell	25,153 -21,392	-46%	-$1.15M	0.05%	356
2021 Q4	$2.88M	Sell	46,545 -1,114	-2%	-$63.4K	0.04%	379
2021 Q3	$2.4M	Buy	47,659 +2,228	+5%	+$113K	0.03%	421
2021 Q2	$2.22M	Sell	45,431 -70	-0.2%	-$3.44K	0.03%	476
2021 Q1	$2.24M	Sell	45,501 -2,182	-5%	-$101K	0.03%	472
2020 Q4	$2.17M	Sell	47,683 -1,657	-3%	-$68.6K	0.03%	444
2020 Q3	$1.76M	Buy	49,340 +817	+2%	+$27.4K	0.03%	467
2020 Q2	$1.36M	Sell	48,523 -12,179	-20%	-$344K	0.02%	562
2020 Q1	$1.51M	Buy	60,702 +57,509	+1,801%	+$1.83M	0.03%	492
2019 Q4	$117K	Buy	3,193 +10	+0.3%	+$328	﹤0.01%	2240
2019 Q3	$90K	Sell	3,183 -1,935	-38%	-$59.8K	﹤0.01%	2358
2019 Q2	$177K	Sell	5,118 -70	-1%	-$2.26K	﹤0.01%	1968
2019 Q1	$144K	Sell	5,188 -97	-2%	-$2.44K	﹤0.01%	2106
2018 Q4	$108K	Buy	5,285 +843	+19%	+$20.7K	﹤0.01%	2222
2018 Q3	$126K	Sell	4,442 -230	-5%	-$6.45K	﹤0.01%	2318
2018 Q2	$137K	Sell	4,672 -846	-15%	-$26.6K	﹤0.01%	2156
2018 Q1	$169K	Buy	5,518 +668	+14%	+$22.3K	﹤0.01%	1994
2017 Q4	$165K	Buy	4,850 +1,620	+50%	+$48.3K	﹤0.01%	2016
2017 Q3	$89K	Buy	3,230 +262	+9%	+$6.17K	﹤0.01%	2419
2017 Q2	$64K	Buy	+2,968	New	+$66.3K	﹤0.01%	2541

Other funds holding IR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s IR Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ingersoll Rand (IR) in Q2 2024, closing a stake of 16,326 shares — an estimated $1.55M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in IR in Q2 2017 and held it in 28 quarters. The position peaked at $2.88M in Q4 2021. 851 funds tracked by Wall St. Rank hold IR as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Ingersoll Rand position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 16,326 Ingersoll Rand shares in Q2 2024, an estimated $1.55M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Ingersoll Rand in Q2 2017 and held it in 28 quarters.
Metropolitan Life Insurance Company (MetLife)'s Ingersoll Rand position peaked at $2.88M in Q4 2021.
851 funds tracked by Wall St. Rank held Ingersoll Rand as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.